Company news
Zhejiang Starry Pharmaceutical Co., Ltd. news in 2024
Zhejiang Starry Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2024, newest first.
Announcement on Circulation of Restricted Shares Issued to Specific Objects
December 8, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
November 15, 2024
Announcement on Passing On-site Inspection by FDA
November 12, 2024
Announcement on "Corporate Value and Return Enhancement" Action Plan
October 30, 2024
Announcement on the Completion of Negotiated Transfer Registration for Partial Shares Held by the Controlling Shareholder and Actual Controller
October 21, 2024